Scarica l'app Stockscreener
8.33
1.19%
-0.10
Dopo l'orario di chiusura:
8.31
-0.02
-0.24%
Corbus Pharmaceuticals Holdings Inc Borsa (CRBP) Ultime notizie
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
How Corbus Pharmaceuticals Holdings Inc. (CRBP) Affects Rotational Strategy Timing - Stock Traders Daily
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corbus Pharmaceuticals shares rise on encouraging safety results for experimental obesity drug - MSN
Downgrade Watch: Will Corbus Pharmaceuticals Holdings Inc 3371 stock top growth indexesMarket Growth Summary & Daily Volume Surge Trade Alerts - moha.gov.vn
Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Below Fifty Day Moving AverageShould You Sell? - MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Corbus Pharmaceuticals announces retirement of board member Holmer - MSN
Why Corbus Pharmaceuticals Holdings Inc. stock could outperform in 2025July 2025 Opening Moves & Weekly Chart Analysis and Guides - DonanımHaber
Can Corbus Pharmaceuticals Holdings Inc. stock sustain institutional interest2025 EndofYear Setup & Fast Exit and Entry Trade Guides - DonanımHaber
Will Corbus Pharmaceuticals Holdings Inc. stock outperform growth indexesQuarterly Trade Review & Growth-Oriented Investment Plans - DonanımHaber
Will Corbus Pharmaceuticals Holdings Inc. stock outperform value stocksJuly 2025 Drop Watch & Consistent Return Strategy Ideas - DonanımHaber
Can Corbus Pharmaceuticals Holdings Inc. stock continue upward trendJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - DonanımHaber
How resilient is Corbus Pharmaceuticals Holdings Inc. stock in market downturnsJuly 2025 Sector Moves & AI Based Trade Execution Alerts - Улправда
Will Corbus Pharmaceuticals Holdings Inc. stock return to pre crisis levelsJuly 2025 Update & Entry and Exit Point Strategies - Улправда
Volume Report: How resilient is Corbus Pharmaceuticals Holdings Inc. stock in market downturnsPortfolio Gains Report & Growth Oriented Trade Recommendations - ulpravda.ru
Cormorant Asset Management, LP Reduces Stake in Corbus Pharmaceu - GuruFocus
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer - TipRanks
Corbus Pharmaceuticals (CRBP) director Alan Holmer resigns from board to retire - Stock Titan
Corbus Pharmaceuticals Holdings, Inc. Announces Resignation of Alan Holmer from its Board of Directors, Effective December 31, 2025 - marketscreener.com
Rally Mode: How resilient is Corbus Pharmaceuticals Holdings Inc. stock in market downturnsJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - Улправда
Corbus Pharmaceuticals Holdings Inc. Stock Slides 8.6%, Underperforms Peers - 富途牛牛
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cormorant Asset Management, Lp Sells 30,029 Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) Stock - MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Corbus Pharmaceuticals (CRBP) insider reports 30,029-share stock sale - Stock Titan
Discipline and Rules-Based Execution in CRBP Response - news.stocktradersdaily.com
Corbus Pharmaceuticals Holdings Inc. (CRBP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CRBP stock surged 36% pre-market – what did its obesity treatment drug study reveal? - MSN
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Corbus Pharmaceuticals (CRBP) Reports Phase 1 Study Results for Obesity Drug - GuruFocus
Corbus declines following early-stage results on oral obesity asset CRB-913 (CRBP:NASDAQ) - Seeking Alpha
CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal? - Stocktwits
CRBP: Corbus Pharmaceuticals' Promising Phase I Study Sparks Int - GuruFocus
CRBP: CRB-913 induced rapid, significant weight loss with minimal side effects in early obesity trials - TradingView — Track All Markets
Corbus Pharmaceuticals Reports Phase 1a Obesity Drug Data Showing Weight Loss - marketscreener.com
Corbus reports positive phase 1 results for obesity drug CRB-913 - Investing.com
Corbus Pharmaceuticals Advances Obesity Treatment with CRB-913 - TipRanks
Corbus Pharmaceuticals Reports Results From Phase 1A Study Of Oral CB1 Inverse Agonist CRB-913 For The Treatment For Obesity Demonstrating Favorable Safety Profile And Emerging Evidence Of Weight Loss - TradingView — Track All Markets
Corbus Pharmaceuticals (CRBP) Advances Obesity Treatment with CR - GuruFocus
Corbus Pharmaceuticals Announces Phase 1a Study Results of CRB-913 - TradingView — Track All Markets
Corbus Pharmaceuticals stock rises after promising obesity drug safety data By Investing.com - Investing.com UK
Corbus reports positive phase 1 results for obesity drug CRB-913 By Investing.com - Investing.com South Africa
Corbus Pharmaceuticals stock rises after promising obesity drug safety data - Investing.com
Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss - Sahm
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Corbus to release phase 1a study results for obesity drug CRB-913 - Investing.com
Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025 - The Manila Times
Corbus Pharmaceuticals to Announce Phase 1a Results for CRB-913 on December 11, 2025 - Quiver Quantitative
Corbus Pharmaceuticals to Report Results from Phase 1a - GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains - 富途牛牛
Will Corbus Pharmaceuticals Holdings Inc. stock remain a Wall Street favoriteMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock trades below fair valueInsider Selling & Free Expert Verified Stock Movement Alerts - Newser
Why Corbus Pharmaceuticals Holdings Inc. (3371) stock attracts wealthy investorsEntry Point & Advanced Technical Signal Analysis - Newser
What risks investors should watch in Corbus Pharmaceuticals Holdings Inc. stock2025 AllTime Highs & Intraday High Probability Alerts - Newser
Is Corbus Pharmaceuticals Holdings Inc. (3371) stock a top dividend aristocrat candidate2025 Big Picture & Real-Time Volume Surge Alerts - Newser
0.08%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):